In light of these considerations, this review aims at summarizing the current knowledge about oxidative stress involvement in the NAFLD–NASH–HCC transition, focusing on the role of the enzymes NADPH oxidases (NOXs). Here, FMO5 is linked to metabolic dysfunction-associated steatotic liver disease.